The Valley Desk

NCT04521231 · Interventional trial

A Study of Subcutaneous Blinatumomab Administration in Participants With R/R and MRD+ B-ALL

Overall registry status Active not recruiting

Phase 1 · Phase 2

Conditions B Cell Precursor Acute Lymphoblastic Leukemia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov